[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-290370-105":59,"doc-detail-290370-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","guidelines-on-the-use-of-therapeutic-apheresis-in-clinical-practice-evidence-based-approach-from-the-writing-committee-of-the-american-society-for-apheresis-the-eighth-special-issue","Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis - The Eighth Special Issue","","The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee develops, updates, and categorizes evidence-based indications for therapeutic apheresis (TA) in human disease. This Eighth Edition applies systematic review and evidence-based grading to produce recommendations across a broad range of diseases and conditions. Using the established category and grading definitions and a fact-sheet structure, it summarizes evidence for TA use per disease entity or medical condition. The edition includes 84 fact sheets with 157 graded and categorized indications and/or TA modalities.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/guidelines-on-the-use-of-therapeutic-apheresis-in-clinical-practice-evidence-based-approach-from-the-writing-committee-of-the-american-society-for-apheresis-the-eighth-special-issue/290370/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/guidelines-on-the-use-of-therapeutic-apheresis-in-clinical-practice-evidence-based-approach-from-the-writing-committee-of-the-american-society-for-apheresis-the-eighth-special-issue/290370.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-20","2026-09-17",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",16,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the purpose of the ASFA JCA Eighth Special Issue guidelines?","Question",{"text":113,"@type":114},"To review, update, and categorize evidence-based indications for therapeutic apheresis in human disease, and to provide recommendations for clinical utilization across many diseases and conditions.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does the Eighth Edition support evidence-based grading and categorization?",{"text":118,"@type":114},"It incorporates systematic review and evidence-based approaches to grading and categorizing apheresis indications, maintaining the established category and grade definitions used in prior editions.",{"name":120,"@type":111,"acceptedAnswer":121},"What does each fact sheet in the Eighth Edition summarize?",{"text":122,"@type":114},"Each fact sheet succinctly summarizes the evidence for TA use in a specific disease entity or medical condition, typically presenting disease name, TA modality, indication(s), category, and grade, using a structured table format.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},290370,1790025837,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":56,"preview_urls":147},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","DOI: 10.1002/jca.21705  \nGuidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence-Based Approach from the Writing Committee of the American Society for Apheresis:  \nThe Eighth Special Issue  \nAnand Padmanabhan1 | Laura Connelly-Smith2 | Nicole Aqui3 | Rasheed A. Balogun4 | Reinhard Klingel5 | Erin Meyer6 | Huy P. Pham7 | Jennifer Schneiderman8 |  \nVolker Witt9 | Yanyun Wu10 | Nicole D. Zantek11 | Nancy M. Dunbar12 | Guest Editor: Joseph Schwartz13  \n1Medical Sciences Institute & Blood Research Institute, Versiti & Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin 2Department of Medicine, Seattle Cancer Care Alliance & University of Washington, Seattle, Washington  \n3Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 4Department of Medicine, University of Virginia, Charlottesville, Virginia  \n5Apheresis Research Institute, Cologne, Germany & First Department of Internal Medicine, University of Mainz, Mainz, Germany 6Department of Hematology/Oncology/BMT/Pathology, Nationwide Children’s Hospital, Columbus, Ohio  \n7Department of Pathology, Keck School of Medicine of the University of Southern California, Los Angeles, California  \n8Department of Pediatric Hematology/Oncology/Neuro-oncology/Stem Cell Transplant, Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern University, Chicago, Illinois  \n9Department for Pediatrics, St. Anna Kinderspital, Medical University of Vienna, Vienna, Austria  \n10Bloodworks NW & Department of Laboratory Medicine, University of Washington, Seattle, Washington, Yale University School of Medicine, New Haven, Connecticut  \n11Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota 12Department of Pathology and Laboratory Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire 13Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York  \nCorrespondence  \nNancy M. Dunbar, MD; DartmouthHitchcock Medical Center, Lebanon, NH 03756 . [Email: nancy.m.dunbar@hitchcock.org](Email: nancy.m.dunbar@hitchcock.org)  \nABSTRACT  \nThe American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special Issue Writing Committee is charged with reviewing, updating and categorizing indications for the evidence-based use of therapeutic apheresis (TA) in human disease. Since the 2007 JCA Special Issue (Fourth Edition), the committee has incorporated systematic review and evidence-based approaches in the grading and categorization of apheresis indications. This Eighth Edition of the JCA Special Issue continues to maintain this methodology and rigor in order to make recommendations on the use of apheresis in a wide variety of diseases/conditions. The JCA Eighth Edition, like its predecessor, continues to apply the category and grading system definitions infact sheets. The general layout and concept of a fact sheet that was introduced in the Fourth Edition, has largely been maintained in this edition. Each fact sheet succinctly  \nJ Clin Apher. 2019;34:171–354.  \n[wileyonlinelibrary.com/journal/jca](wileyonlinelibrary.com/journal/jca)  \n© 2019 Wiley Periodicals, Inc.  \n171  \n1 | INTRODUCTION  \nsummarizes the evidence for the use of TA in a specific disease entity or medical condition. The Eighth Edition comprises 84 fact sheets for relevant diseases and medical conditions, with 157 graded and categorized indications and/or TA modalities. The Eighth Edition of the JCA Special Issue seeks to continue to serve as a key resource that guides the utilization of TA in the treatment of human disease.  \ntable, disease description, current management, rationale for TA, technical notes (e.g., volumes treated, frequency, replace-  \nThe Writing Committee of the Journal of Clinical Apheresis (JCA) Special Issue 2019 is pleased to present the Eighth Edition of the JCA Special Issue. After more than 2 ","cbCailcWvANToAMP","https://ap.wps.com/l/cbCailcWvANToAMP","pdf",3565897,184,"English","# Introduction\n## Purpose and scope of the Eighth Edition\n## Fact-sheet structure and terminology\n## Indications, categories, and grades","[{\"question\":\"What is the purpose of the ASFA JCA Eighth Special Issue guidelines?\",\"answer\":\"To review, update, and categorize evidence-based indications for therapeutic apheresis in human disease, and to provide recommendations for clinical utilization across many diseases and conditions.\"},{\"question\":\"How does the Eighth Edition support evidence-based grading and categorization?\",\"answer\":\"It incorporates systematic review and evidence-based approaches to grading and categorizing apheresis indications, maintaining the established category and grade definitions used in prior editions.\"},{\"question\":\"What does each fact sheet in the Eighth Edition summarize?\",\"answer\":\"Each fact sheet succinctly summarizes the evidence for TA use in a specific disease entity or medical condition, typically presenting disease name, TA modality, indication(s), category, and grade, using a structured table format.\"}]","Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis - The Eighth Special Issue | PDF",1789641512,464,[148,152,156,160,164,168,172,176,180,184,188,193,198,203,208,213,217,222,227],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d9e135d67e41e29923fccba081a7921c.webp",983,1291,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c62519fea83c5349c8f0f1ce0cf03385.webp",982,1290,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33f220da0b49381d33f6862db8af8534.webp",981,1289,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e0197535ac1c10ed71366bd2fae3677.webp",980,1287,{"page_no":24,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c22963e5b1d2bcf4a51dea034b392b8.webp",979,1286,{"page_no":29,"url":169,"width":170,"height":171},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff01de721d18256dd9ec972330489e8e.webp",978,1285,{"page_no":34,"url":173,"width":174,"height":175},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2e51e1cf0409fa9ddb474b37ff331439.webp",977,1283,{"page_no":39,"url":177,"width":178,"height":179},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b03646e349e2ef838a3aefed3be8d723.webp",976,1282,{"page_no":44,"url":181,"width":182,"height":183},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/403f6476ae3170afa4536e576bb798e9.webp",975,1281,{"page_no":52,"url":185,"width":186,"height":187},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b7ed2cd9c25d624023ae02fcd04cc5d.webp",974,1279,{"page_no":189,"url":190,"width":191,"height":192},11,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/48875f7979fb09fb39267d5ae188ae30.webp",973,1278,{"page_no":194,"url":195,"width":196,"height":197},12,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1f0ff7fbc303876d38af551fd6ed53c.webp",972,1277,{"page_no":199,"url":200,"width":201,"height":202},13,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3f585721bf6239d921972f7787949514.webp",971,1275,{"page_no":204,"url":205,"width":206,"height":207},14,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7304beb06ac4e7fdab9f4eefe2a478ab.webp",970,1274,{"page_no":209,"url":210,"width":211,"height":212},15,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/530c9e1ace7f4fb0514b4e9bee4c63ad.webp",969,1273,{"page_no":105,"url":214,"width":215,"height":216},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64ad1db0828e61bc52c6dca2ed929165.webp",968,1272,{"page_no":218,"url":219,"width":220,"height":221},17,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/04547e03370b55b91c1e8cf879abdcbb.webp",967,1270,{"page_no":223,"url":224,"width":225,"height":226},18,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ecd4a696ec71edd3d943043668f3a1c.webp",966,1269,{"page_no":56,"url":228,"width":229,"height":230},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/64bbe9ebc1ffb376667364f0cbd511d9.webp",965,1268]